Private company

OTR Acquisition Corp.

American pharmaceutical preparations company, incorporated in Delaware1

In its 2022 annual report the company says: “We are a blank check company formed under the laws of the State of Delaware on July 23, 2020. Our Sponsor is OTR Acquisition Sponsor LLC, a Delaware limited liability company. Our Sponsor is controlled by affiliates of Nicholas J. Singer, our Chairman and Chief Executive Officer, and Purchase Capital LLC, an investment firm founded by Mr. Singer.”30 It is headquartered in Miami, Florida.1

Last updated Oct 21, 2026.

Overview

$4.7MNet income, fiscal 20212
  • IndustryPharmaceutical Preparations1
  • HeadquartersMiami, Florida1
  • Incorporated inDE3
  • Business address1395 Brickell Avenue, Suite 800, Miami, Fl 331313
  • Filer category, Emerging growth company3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Fiscal year20202021
Operating expenses$1.1M2
Operating income-$1.1M2
Income tax$02
Net income$4.7M2

Compare OTR Acquisition Corp. with another company

Corporate structure

OTR Acquisition Corp. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of OTR Acquisition Corp.

  • OTR Acquisition Corp. Miami, Florida

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What OTR Acquisition Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$991.7K5 Dec 31, 2020

Leadership

Who has led OTR Acquisition Corp., and when. Pick a name to see everywhere that person has worked.

Chief financial officer

  1. Douglas Brian Anderson2020–2022
2025
Board members and other officers (5)

Timeline

  1. May 24, 20228-K Entered a material agreement; Ended a material agreement; Completed an acquisition or sale11
  2. May 18, 20228-K Other events12
  3. May 17, 20228-K Other events13
  4. May 16, 20228-K Other events14
  5. May 13, 20228-K Shareholder vote; Other events15
  6. May 12, 20228-K Shareholder vote16
  7. Mar 2, 20228-K Entered a material agreement; New debt or obligation17
  8. Feb 4, 20228-K Entered a material agreement; Other events18
  9. Jan 31, 20228-K Regulation FD disclosure; Other events19
  10. Nov 30, 20218-K Earlier financial statements no longer reliable20

Filings

58 filings to the SEC since October 2021: 3 annual reports, 3 quarterly reports, 10 major events, 14 insider forms, 13 large holders, 15 other. The latest 20:

  1. Feb 13, 2023SC 13G/A EDGAR
  2. Feb 6, 2023SC 13G/A BANK OF MONTREAL EDGAR
  3. Jan 24, 2023SC 13G/A EDGAR
  4. May 31, 202215-12B EDGAR
  5. May 24, 20228-K EDGAR
  6. May 20, 2022SC 13G/A EDGAR
  7. May 20, 20224 OWNERSHIP DOCUMENT EDGAR
  8. May 20, 20224 OWNERSHIP DOCUMENT EDGAR
  9. May 20, 20224 OWNERSHIP DOCUMENT EDGAR
  10. May 20, 20224 OWNERSHIP DOCUMENT EDGAR
  11. May 20, 20224 OWNERSHIP DOCUMENT EDGAR
  12. May 20, 20224 OWNERSHIP DOCUMENT EDGAR
  13. May 20, 20224 OWNERSHIP DOCUMENT EDGAR
  14. May 18, 2022425 EDGAR
  15. May 18, 20228-K EDGAR
  16. May 17, 2022425 EDGAR
  17. May 17, 20228-K EDGAR
  18. May 16, 2022425 EDGAR
  19. May 16, 20228-K EDGAR
  20. May 13, 202210-Q EDGAR

The 58 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How OTR Acquisition Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGAROTR Acquisition Corp.1
  • CIK0001821318
  • Employer ID (EIN)85-21369141
  • Filer status<br>emerging growth company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • Business address1395 Brickell Avenue, Suite 800, Miami, FL 331311
  • Phone30569796101
  • Public float$106.7M as of Jun 30, 20212
  • On EDGAR sinceAug 18, 20201
  • Filings90 in all: 4 (14), 8-K (14), 425 (13), SC 13G (11), SC 13G/A (8), 3 (7), 10-Q (5), 10-K/A (3)1
    All 21 form types

    10-K (2), S-1/A (2), 10-Q/A (1), 15-12B (1), 25-NSE (1), 424B4 (1), 8-A12B (1), 8-K/A (1), CERT (1), DEFM14A (1), EFFECT (1), NT 10-Q (1), S-1 (1)

  • Latest filingsAnnual report (10-K) Mar 8, 2022
    Quarterly report (10-Q) May 13, 2022
    Latest 8-K (8-K) May 24, 2022

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
    SEC EDGAROther events
  13. 13
    SEC EDGAROther events
  14. 14
    SEC EDGAROther events
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30